Join our Newsletter
To receive News as it is released, please sign up.
September 13, 2021
Spectral MD has achieved all the project milestones it set to be achieved by this time in 2021 and has achieved other important milestones ahead of schedule, including early receipt of increased U.S. Government grant funding of c. US $20 million post-IPO and progress on new burn and DFU patient studies.
September 7, 2021
Wensheng Fan, Chief Executive Officer, and Wan Lung Eng, Chief Financial Officer, will provide a live presentation relating to the Company’s interim results via the Investor Meet Company platform on Monday, 13 September at 16:30hrs BST.
September 6, 2021
This contract option funding of $18.8 million under Option 1B of Spectral MD’s current contract with BARDA follows the $20.6 million awarded under Option 1A which was exercised by BARDA in March 2021 to execute the first stage of the clinical training study at five sites to train the DeepView® AI algorithm.
August 9, 2021
Spectral MD welcomed physicians, clinical coordinators, and researchers from five clinical candidate sites across the United States to the kick-off event. Over the two-days, Spectral MD showcased its next generation, user-friendly DeepView® technology to physicians, clinical coordinators, and researchers from the five candidate sites.
July 15, 2021
TR-1: Standard form for notification of major holdings.
June 24, 2021
This Contract will support Spectral MD in advancing a new, multispectral imaging ("MSI") sensor intended to enable the development of a fully handheld version of DeepView™, Spectral MD's existing AI and MSI technology for early burn wound healing assessment, in a far-forward military environment.
June 22, 2021
Oversubscribed Placing for gross proceeds of £11.3 million (c.US$16 million). Click to the summary and highlights here.
June 16, 2021
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.
THESE SECURITIES WILL BE OFFERED ONLY OUTSIDE OF THE UNITED STATES TO NON-U.S. PERSONS, PURSUANT TO THE PROVISIONS OF REGULATION S OF THE U.S. SECURITIES ACT OF 1933, AS AMENDED. THESE SECURITIES WILL NOT BE REGISTERED UNDER THE SECURITIES ACT, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS.
June 7, 2021
Wound care AI company, focused on predictive analytics for faster treatment decisions to seek admission to AIM and raise funding through an IPO.
April 20, 2021
A company using technology for assessing wounds is getting more funding.
April 7, 2021
Spectral MD receives funding to further develop its artificial intelligence for wound healing assessment.
February 2, 2021
Spectral MD's DeepView imaging device collected data from 124 Adult and Pediatric Subjects to further develop its burn wound-healing prediction AI Algorithm
Spectral MD and RCSI to Advance Care for Chronic Wounds
December 17, 2020
Spectral MD and Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences Skin Wounds, and Trauma (SWaT) Research Center will collaborate to provide scientific oversight and assessment of the clinical value of Spectral MD's DeepView technology in chronic wounds
Spectral MD Initiates Multi-Center Clinical Study for Diabetic Foot Ulcer
December 17, 2020
Spectral MD's DeepView Wound Imaging System will collect critical data to further develop its multi-spectral imaging and artificial intelligence-based wound-healing prediction technology
Spectral MD Appoints Dr. Jeffrey Carter as Chief Medical Consultant and Wan Lung Eng as Chief Financial Officer
December 1, 2020
Spectral MD broadens the company's executive leadership team with the addition of two new members
Spectral MD and the American College of Cardiology to Advance Care for Critical Limb Ischemia
July 21, 2020
Spectral MD and the ACC will collaborate to provide scientific oversight and assessment of the clinical value of Spectral MD's DeepView technology to detect and assess critical limb ischemia
Spectral MD Names New CEO
June 29, 2020
Co-Founder Wensheng Fan, Spectral MD's Current COO, Promoted to CEO
Spectral MD and BARDA Agree to Start Enrollment in Clinics for Expanded Proof Of Concept Study (ePOC) Stage II Using the Company’s Improved DeepView SnapShot® Device
June 3, 2020
Spectral MD, Inc. (SMD) announced today that the Biomedical Advanced Research and Development Authority (BARDA) has agreed with SMD to proceed with Stage II enrollment for the ePOC after reviewing the performance of their next-generation imaging head in their Stage I ePOC study.
Spectral MD Welcomes Former Cleveland Clinic CEO Toby Cosgrove to the Spectral MD Board of Advisors
May 19, 2020
Toby Cosgrove joins the Spectral MD Board of Advisors and will assist all aspects of the Company's progression, including with burn and diabetic foot ulcer clinical trial and other strategic introductions.
New technology at UMC Burn Center
January 7, 2020
Fox 8 Live news talks to University Medical Center (UMC) Burn Center regarding burn wounds and how they are treated using DeepView®.
Credit: Fox 8 Local First
Modernizing wound care with Spectral MD, powered by Amazon SageMaker
August 15, 2019
Amazon Web Services (AWS) Machine Learning Blog
Spectral MD Receives Substantial Funding from BARDA for Continued Development of Spectral MD’s DeepView® Biomedical Imaging Device
July 23, 2019
Spectral MD receives $27 million under a 22-month contract, which can be extended for a total of up to $92 million
U.S. Invests In Burn Imaging Device For Mass Casualty Preparedness
July 19, 2019
CBRNE Central: Mass Casualty Preparedness Notable Contracts, Spectral MD
U.S. Department of Health and Human Services (HHS) sponsors development of portable, user-friendly burn imaging device
July 18, 2019
Program advances next-generation technology to improve care for burn patients.